Solasia Pharma K.K. (TYO:4597)

Japan · Delayed Price · Currency is JPY

28.00

0.00 (0.00%)

Aug 4, 2026, 1:54 PM JST

Solasia Pharma K.K. Financials Overview

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	410	429	316	617	1,092	559
Revenue Growth	24.24%	35.76%	-48.78%	-43.50%	95.35%	23.13%
Gross Profit	207	208	185	337	662	374
Operating Income	-868	-859	-1,950	-1,139	-2,471	-2,419
Net Income	-891	-876	-1,941	-1,112	-2,548	-2,478
Earnings Per Share	-3.56	-3.69	-9.77	-6.62	-16.77	-19.04
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Japan	133	129	81	323	243
China and Others	295	187	536	768	315
Total	428	316	617	1,091	558

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,569	1,387	886	728	803	714
Total Debt	86	95	25	60	37	84
Net Cash (Debt)	1,483	1,292	861	668	766	630
Net Cash Growth	41.51%	50.06%	28.89%	-12.79%	21.59%	-66.91%
Net Cash Per Share	5.93	5.44	4.33	3.97	5.04	4.84

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1,121	-847	-1,033	-359	-2,074	-2,473
Capital Expenditures	-	-	-1	-	-	-2
Free Cash Flow	-1,121	-847	-1,034	-359	-2,074	-2,475
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	50.49%	48.48%	58.54%	54.62%	60.62%	66.91%
Operating Margin	-211.71%	-200.23%	-617.09%	-184.60%	-226.28%	-432.74%
Pretax Margin	-217.32%	-204.20%	-620.25%	-183.95%	-228.21%	-437.03%
Profit Margin	-217.32%	-204.20%	-614.24%	-180.23%	-233.33%	-443.29%
FCF Margin	-273.42%	-197.44%	-327.21%	-58.18%	-189.93%	-442.75%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	18.64	17.63	24.83	12.28	7.54	25.56